- Type I DM:
- Usual daily maintenance range is 0.5-1 unit/kg/day in divided doses
- Usual daily maintenance range is 0.5-1 unit/kg/day in divided doses
- Type II DM:
- Dose is individualized
Injection/pre-filled syringe: 100 IU/mL
- Administer dose within 15 minutes before a meal or immediately after a meal.
- Administer by SC injection in the abdominal wall, thigh, upper arm or buttocks
- Rotate injection sites within the same region from 1 injection to the next to reduce the risk of lipodystrophy
Rapid-acting insulin
It stimulates peripheral glucose uptake, inhibits hepatic glucose production, inhibits lipolysis and proteolysis regulating glucose metabolism
- Hypoglycemia
- Injection site reaction
- Injection site lipodystrophy
- Myalgia
- Nasopharyngitis
- Pruritus
- Rash
- URI
- Weight gain
- Headache
- Peripheral edema
- Hypersensitivity reaction
- Influenza
- Hypersensitivity to components
- IV use
- Hypoglycemia
- Pramlintide
Drug Status
| Availability | Prescription only |
| Pregnancy | Category B; Can be used |
| Breastfeeding | Can be used |
| Schedule | Not controlled |
| BRAND NAME | STRENGTH | FORMULATION | PACK SIZE | MANUFACTURER | DISTRIBUTOR |
|---|---|---|---|---|---|
| Humalog | 100 IU/mL | Injection (cartridge) | 3mL | Eli Lilly | Statim Pharma |
| Humalog | 100 IU/mL | Injection (vial) | 10mL | Eli Lilly | Statim Pharma |
| Humalog Kwikpen | 100 IU/mL | Pre-Filled Syringe | 3mL*5’s | Eli Lilly | Statim Pharma |